Literature DB >> 3018744

Reaction of DNA with chemically or enzymatically activated mitomycin C: isolation and structure of the major covalent adduct.

M Tomasz, D Chowdary, R Lipman, S Shimotakahara, D Veiro, V Walker, G L Verdine.   

Abstract

The antitumor antibiotic mitomycin C is shown to form a covalent complex with calf thymus DNA under anaerobic conditions in the presence of either NADPH cytochrome c reductase/NADPH, xanthine oxidase/NADH, or the chemical reducing system H2/PtO2. Digestion of the complex with DNase I/snake venom diesterase/alkaline phosphatase yields a single mitomycin deoxyguanosine adduct as the major DNA alkylation product, identified as N2-(2'' beta,7''-diaminomitosen-1'' alpha-yl) 2'-deoxyguanosine (Structure 2). Two minor adducts, 2-5% each of the total adduct pool, are isolated and identified as the 1'' beta stereoisomer of 2 (Structure 3), and 10''-decarbamoyl-2 (Structure 7). The same results were obtained with M13 DNA and poly(dG-dC).poly(dG-dC); however, in the latter case, a minor adduct apparently possessing two deoxyguanosine and one mitomycin unit is isolated. Digestion of the covalent mitomycin-calf thymus DNA complex with nuclease P1 yields four dinucleotide adducts, all of which consist of 2 linked at its 3' end to each of the four possible 5' nucleotides (A, T, G, and C). Upon treatment of each dinucleotide adduct with snake venom diesterase/alkaline phosphatase, 2 is released along with the corresponding free nucleoside. In apparent conflict with the present results, previous reports from another laboratory have indicated that modification of calf thymus DNA by mitomycin C under conditions identical to those described here result in the isolation of three mitomycin C mononucleotide adducts possessing linkages of the drug to N2 and O6 of guanine and N6 of adenine. Evidence is shown suggesting that the latter adducts are actually three of the above four dinucleotide derivatives of 2 obtained independently by us and, thus, all of them in fact possess an identical N2-mitosenylguanine adduct moiety. Model-building studies indicate an excellent fit of the guanine N2-linked drug molecule inside the minor groove of B-DNA with no appreciable distortion of the DNA structure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018744      PMCID: PMC386577          DOI: 10.1073/pnas.83.18.6702

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  GENETIC CONTROL OF DNA BREAKDOWN AND REPAIR IN E. COLI K-12 TREATED WITH MITOMYCIN C OR ULTRAVIOLET LIGHT.

Authors:  R P BOYCE; P HOWARD-FLANDERS
Journal:  Z Vererbungsl       Date:  1964-12-30

2.  Circular dichroism of mitomycin-DNA complexes. Evidence for a conformational change in DNA.

Authors:  C M Mercado; M Tomasz
Journal:  Biochemistry       Date:  1977-05-03       Impact factor: 3.162

3.  The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro.

Authors:  M Tomasz; C M Mercado; J Olson; N Chatterjie
Journal:  Biochemistry       Date:  1974-11-19       Impact factor: 3.162

4.  Preparation and characterization of monodisperse, cross-linked low molecular weight deoxyribonucleic acid.

Authors:  R J Cohen; D M Crothers
Journal:  Biochemistry       Date:  1970-06-09       Impact factor: 3.162

5.  Reductive metabolism and alkylating activity of mitomycin C induced by rat liver microsomes.

Authors:  M Tomasz; R Lipman
Journal:  Biochemistry       Date:  1981-08-18       Impact factor: 3.162

6.  A screening method for isolating DNA repair-deficient mutants of CHO cells.

Authors:  L H Thompson; J S Rubin; J E Cleaver; G F Whitmore; K Brookman
Journal:  Somatic Cell Genet       Date:  1980-05

7.  Electrostatic complexes of mitomycin C with nucleic acids and polyanions.

Authors:  R Lipman; J Weaver; M Tomasz
Journal:  Biochim Biophys Acta       Date:  1978-12-21

8.  DNA crosslinking, sister-chromatid exchange and specific-locus mutations.

Authors:  A V Carrano; L H Thompson; D G Stetka; J L Minkler; J A Mazrimas; S Fong
Journal:  Mutat Res       Date:  1979-11       Impact factor: 2.433

9.  Pyrrol[1,4]benzodiazepine antibiotics. Proposed structures and characteristics of the in vitro deoxyribonucleic acid adducts of anthramycin, tomaymycin, sibiromycin, and neothramycins A and B.

Authors:  R L Petrusek; G L Anderson; T F Garner; Q L Fannin; D J Kaplan; S G Zimmer; L H Hurley
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

10.  DNA-damaging agents stimulate gene expression at specific loci in Escherichia coli.

Authors:  C J Kenyon; G C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  30 in total

1.  Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediates.

Authors:  Kathryn E Pietsch; James F Neels; Xiang Yu; Jiachang Gong; Shana J Sturla
Journal:  Chem Res Toxicol       Date:  2011-10-14       Impact factor: 3.739

2.  Porfiromycin disposition in oxygen-modulated P388 cells.

Authors:  S S Pan
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 3.  Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.

Authors:  Angelo Guainazzi; Orlando D Schärer
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

4.  Zn2+-dependent deoxyribozymes that form natural and unnatural RNA linkages.

Authors:  Kelly A Hoadley; Whitney E Purtha; Amanda C Wolf; Amber Flynn-Charlebois; Scott K Silverman
Journal:  Biochemistry       Date:  2005-06-28       Impact factor: 3.162

5.  Partial complementation of the Fanconi anemia defect upon transfection by heterologous DNA. Phenotypic dissociation of chromosomal and cellular hypersensitivity to DNA cross-linking agents.

Authors:  C Diatloff-Zito; F Rosselli; J Heddle; E Moustacchi
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

6.  Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.

Authors:  Manuel M Paz; Sweta Ladwa; Elise Champeil; Yanfeng Liu; Sara Rockwell; Ernest K Boamah; Jill Bargonetti; John Callahan; John Roach; Maria Tomasz
Journal:  Chem Res Toxicol       Date:  2008-12       Impact factor: 3.739

7.  Modulation of mesangial cell proliferation by endothelial cells in coculture.

Authors:  T Saeki; T Morioka; M Arakawa; F Shimizu; T Oite
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

8.  Interdependent Sequence Selectivity and Diastereoselectivity in the Alkylation of DNA by Decarbamoylmitomycin C.

Authors:  William Aguilar; Manuel M Paz; Anayatzinc Vargas; Maggie Zheng; Shu-Yuan Cheng; Elise Champeil
Journal:  Chemistry       Date:  2018-08-10       Impact factor: 5.236

Review 9.  Mitomycinoid alkaloids: mechanism of action, biosynthesis, total syntheses, and synthetic approaches.

Authors:  Phillip D Bass; Daniel A Gubler; Ted C Judd; Robert M Williams
Journal:  Chem Rev       Date:  2013-05-08       Impact factor: 60.622

10.  Formation of adriamycin--DNA adducts in vitro.

Authors:  C Cullinane; S M Cutts; A van Rosmalen; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.